DCGI

Many media portals ran the 'news' declaring that the new eye drops by Entod Pharmaceuticals will help persons with presbyopia get rid of glasses. Naturally, curiosity around the product was spiked and some news reports and social media posts even hailed it as a remarkable innovation.

Confirming the development, Abbott India stated that it is going ahead with voluntary recall, however, it added that it was an "isolated customer complaint on taste and odour".

Booster dose of COVAXIN is safe and may be necessary to ensure persistent immunity to prevent breakthrough infections.

DCGI has granted emergency use approval for Bharat Biotech's Covaxin for people in the age group 12 years to 18 years.

Zydus-Cadila ZyCoV-D Covid-19 vaccine has received Emergency Use Authorization (EUA) from the DCGI.

CMC Vellore will conduct a study and clinical trial to determine if a person can take two different vaccine shots of Covidshield and Covaxin to complete the vaccination course.

Sharvil Patel, MD, Cadila Healthcare said, "As the first-ever plasmid DNA vaccine for human use, ZyCoV-D has proven its safety and efficacy profile in our fight against Covid-19".